Source: Korea Biomedical Review

QuantaMatrix: QuantaMatrix shares shoot up 30% after Nature publication on super-fast sepsis diagnostic technology

Shares of QuantaMatrix, an in-vitro diagnostics company specializing in sepsis diagnostics solutions, surged by 30 percent to 6,660 won ($4.82) on Thursday, after announcing that its ultra-rapid antimicrobial susceptibility testing (uRAST) technology has been featured in the journal Nature. This mar

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
SungHoon Kwon's photo - President & CEO of QuantaMatrix

President & CEO

SungHoon Kwon

CEO Approval Rating

82/100

Read more